al trials for Tysabri and Gilenya and, if so, (ii) did they receive any financial assistance from Biogen Idec and Novartis, (iii) did the Society or any of its board members, scientists or other members provide any support or recommendation for the drugs to the government, (iv) did the Society or any of its board members, scientists or other members serve on any expert panel to the government rega